Table 3.
Outcomes of subgroup analyses of hydrogen/oxygen therapy in ordinary COVID-19 patients
Group | Median length of hospitalization (95% CI) | P value |
---|---|---|
Age | 0.028 | |
≥ 55 (n = 21) | 14.0 (9.0, 17.0) | |
< 55 (n = 21) | 10.0 (9.0, 13.0) | |
Gender | 0.684 | |
Male (n = 14) | 13.0 (8.0, 16.0) | |
Female (n = 28) | 10.0 (10.0, 13.0) | |
Comorbidities | 0.002 | |
With comorbidities (n = 18) | 15.5 (10.0, 17.0) | |
Without comorbidities (n = 24) | 10.0 (9.0, 12.0) | |
Duration between onset and hospitalization | 0.140 | |
0–14 days (n = 8) | 12.5 (9.0, 27.0) | |
> 14 days (n = 34) | 10.0 (9.0, 14.0) |